Gene · 8932
Papers2,613
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
561 to 580 of 2,613
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| 5-Methylcytosine-Related Long Noncoding RNAs Are Potential Biomarkers to Predict Overall Survival and Regulate Tumor-Immune Environment in Patients with Bladder Cancer. | Dis Markers | 2022 | 35371346 | PubTator, text mining | PubMed |
| Inhibition of Histone H3 Lysine-27 Demethylase Activity Relieves Rheumatoid Arthritis Symptoms via Repression of IL6 Transcription in Macrophages. | Front Immunol | 2022 | 35371061 | PubTator, text mining | PubMed |
| Characterization of aging tumor microenvironment with drawing implications in predicting the prognosis and immunotherapy response in low-grade gliomas. | Sci Rep | 2022 | 35361903 | PubTator, text mining | PubMed |
| Modification Patterns of DNA Methylation-Related lncRNAs Regulating Genomic Instability for Improving the Clinical Outcomes and Tumour Microenvironment Characterisation of Lower-Grade Gliomas. | Front Mol Biosci | 2022 | 35359593 | PubTator, text mining | PubMed |
| Genetic or siRNA inhibition of MBD2 attenuates the UUO- and I/R-induced renal fibrosis via downregulation of EGR1. | Mol Ther Nucleic Acids | 2022 | 35356685 | PubTator, text mining | PubMed |
| Epigenetic Modifications in the Pathogenesis of Systemic Sclerosis. | Int J Gen Med | 2022 | 35342304 | PubTator, text mining | PubMed |
| Lysine (K)-specific demethylase 5C regulates the incidence of severe preeclampsia by adjusting the expression of bone morphogenetic protein-7. | Bioengineered | 2022 | 35331081 | PubTator, text mining | PubMed |
| The Role of LSD1 and LSD2 in Cancers of the Gastrointestinal System: An Update. | Biomolecules | 2022 | 35327654 | PubTator, text mining | PubMed |
| DNA Methylation Malleability and Dysregulation in Cancer Progression: Understanding the Role of PARP1. | Biomolecules | 2022 | 35327610 | PubTator, text mining | PubMed |
| The Role of Epigenetic Modifications in Human Cancers and the Use of Natural Compounds as Epidrugs: Mechanistic Pathways and Pharmacodynamic Actions. | Biomolecules | 2022 | 35327559 | PubTator, text mining | PubMed |
| In Silico Evaluation of Antifungal Compounds from Marine Sponges against COVID-19-Associated Mucormycosis. | Mar Drugs | 2022 | 35323514 | PubTator, text mining | PubMed |
| Common Molecular Pathways Between Post-COVID19 Syndrome and Lung Fibrosis: A Scoping Review. | Front Pharmacol | 2022 | 35308222 | PubTator, text mining | PubMed |
| Oncogenic and Tumor-Suppressive Functions of the RNA Demethylase FTO. | Cancer Res | 2022 | 35303057 | PubTator, text mining | PubMed |
| Interactions of circRNAs with methylation: An important aspect of circRNA biogenesis and function (Review). | Mol Med Rep | 2022 | 35302170 | PubTator, text mining | PubMed |
| miR-221/222 as biomarkers and targets for therapeutic intervention on cancer and other diseases: A systematic review. | Mol Ther Nucleic Acids | 2022 | 35282417 | PubTator, text mining | PubMed |
| Trained immunity: A Yin-Yang balance. | MedComm (2020) | 2022 | 35281787 | PubTator, text mining | PubMed |
| Methyl-CpG binding proteins (MBD) family evolution and conservation in plants. | Gene | 2022 | 35278634 | PubTator, text mining | PubMed |
| SEEMLIS: a flexible semi-automated method for enrichment of methylated DNA from low-input samples. | Clin Epigenetics | 2022 | 35272673 | PubTator, text mining | PubMed |
| OpenCell: Endogenous tagging for the cartography of human cellular organization. | Science | 2022 | 35271311 | PubTator, text mining | PubMed |
| PGM1 and ENO1 Promote the Malignant Progression of Bladder Cancer via Comprehensive Analysis of the m6A Signature and Tumor Immune Infiltration. | J Oncol | 2022 | 35251177 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8932/papers?page=29